))
Rebooting generics to fight cancer | Talking Precision Medicine #21
Manage episode 332686300 series 3103485
Konten disediakan oleh Genialis. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Genialis atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Reboot Rx is a different kind of biotech startup. Reboot’s mission is to find generic non-cancer drugs that can benefit cancer patients quickly and affordably. And as a not-for-profit, Reboot can stay focused on its mission. Given the number of paradigms Reboot hopes to shift at once, we decided to talk with all three co-founders: CEO Laura Kleiman, COO & CTO Pradeep Mangalath and CSO Catherine Del Vecchio Fitz. Each one provides perspective on their part of the puzzle.
Visit TPM E21 for highlights and links from this episode.
35 episode
Bagikan
